001
002
003
004 Macromill Others No.1 (4) 40.0 32.5 35.5 19% 28.7 (Dentsu Macromill) 21.3 17.1 14.2 12.2 32% 12% 11% 9% 69% 2001/6 2002/6 2003/6 2004/6 2005/6 2006/6 2007/6 2008/6 2009/6 2010/6 2011/6 2012/6 2013/6 2014/6 2015/6 2016/6 2017/6 2018/6 (IFRS)
005
006
007
008
009
010 +13% +10% 40,024 38,975 +3% +1% 35,514 1,680 1,550 8,531 8,757 8,637 +13% +11% 7,696 8,660 8,540 4,249 4,813 4,727 3,706 4,719 4,633 24.0% 21.9% 22.2% 12.0% 12.0% 12.1% 21.7% 21.6% 21.9% 10.4% 11.8% 11.9%
011 +7% DMP Solutions +52% B-HEALTH +178% 25,667 27,448 +17% +10% +15% +1% +51% Track-360 +39% +27% +16% 10,025 12,721 1,650 11,661 1,520 +50% +42% 6,588 6,238 4,392
M&A -1.5% +12.5% +7.7% +2.6% 8,531 240 68 9,149 8,757 792 216 (392) + (398) (301) 8,133 012
013 21.9% 154 143 137 134 129 21.6% 17.8% 104 11.4% 10.7% 10.6% 7.0% (5) Buy Segment (8)
014 +13.3% +20.8% 105 176 32 66 (263) 4 442 4,813 4,249 3,986
015 362 102.6% 389 99.9% 86 93.2% 86 91.9% 69 90.6% 75 89.7% 42 98.2% 47 96.5%
016
017 450 CAGR: 2% (3) 170 CAGR: 11% (3) 2 5,440 CAGR: 7% (4) 1,920 CAGR: 15% (4) 1 2 3 3 6 (5) CAGR: 5% (3) 20 (5) CAGR: 3% (3) 1 Global Market Research spending: ESOMAR- Global Market Research (2015/9, 2016/9, 2017/9) Japan Market Research spending: Japan Marketing Research Association (2016/7, 2017/7, 2018/7) Ad spending: emarketer- Worldwide Ad Spending (2016/10, 2017/10)
018 +10% +6% 37% +16% +9% +13% 40% 32.5 35.5 40.0 46.4 17% 20%
019 +17% +3% +19% +10% +13% 7.14 8.53 8.75 10.20 +22% 3.49 4.24 4.81 5.30
020 +16.5% +2.6% +12.5% +19.4% +7.7% 8,133 10,200 9,149 8,757 8,531 8,531 7,146
021 130 (89) (402) +13.0% +10.1% 1,007 (139) +13.3% (20) 32 244 105 (263) 4 442 4,813 5,439 5,300 4,249
022 +17% +17% +13% +17% +19% +11% +11% +27% +31% 10.16 8.66 7.69 6.60 5.73 6.82 7.60 8.90 2.83 3.70 4.71 5.26 20.3% 21.7% 21.6% 21.9% 17.6% 19.2% 19.0% 19.2% 8.7% 10.4% 11.8% 11.3%
023 7,047 (4) 5,733 5,610 4,665 2,298 (821) (672) (2,036) (1,657) 7.0x 5.0x 3.6x 3.2x 4.8% 3.7% 2.0% 1.8%
025
026
027
22% 6% 16% 13% 40,024 20% 10% 13% 23% 6% 16% 13% 38,344 20% 8% 14% 22% 24% 7% 6% 16% 16% 13% 13% 35,514 32,504 18% 20% 9% 9% 13% 13% 028
029 +5% Q1 Q1-2 +8% +9% Q1 Q1-2 Q1-3 +11% Q1-3 +5% +6% +8% +5% Q1 Q1-2 -11% -7% Q1 Q1-2 Q1-3 -1% Q1-3 -12% -8% -2% Q1 +3% Q1 +1% +8% +13% +10% +5% Q1-2 +20% Q1-2 +17% 40,024 38,975 +3% +1% Q1-3 +13% Q1-3 +11% 35,514 1,680 1,550 8,531 8,757 8,637 +13% +11% 7,696 8,660 8,540 4,249 4,813 4,727 3,706 4,719 4,633 24.0% 21.9% 22.2% 12.0% 12.0% 12.1% 21.7% 21.6% 21.9% 10.4% 11.8% 11.9%
030 2% +10% 28% +14% 35% +5 25,667 +7% 27,448 +17% +10% +15% +1% DMP Solutions +52% B-HEALTH +178% +51% Track-360 +39% +27% +16% 10,025 12,721 1,650 11,661 1,520 +50% +42% 6,588 6,238 4,392
031 Q1 Q2 Q3 Q4 1,477 1,472 1,680 1,316 5,946 1,322 1,606 1,647 1,278 5,853 (155) 134 (33) (38) (92) (10.5%) 9.1% (2.0%) (2.9%) (1.6%) 219 226 230 231 906 140 185 152 174 651 (74) (51) (74) (57) (255) (36.1%) (18.2%) (34.1%) (24.7%) (28.2%) Q1 Q2 Q3 Q4 ( Normalized (3) 245 434 372 159 1,210 1,076 136 286 326 174 922 922 (109) (148) (46) 14 (288) (154) (44.5%) (34.1%) (12.5%) 9.2% (23.8%) (14.4%) ) 35 31 22 16 104 (10) 3 (8) 8 (5) (44) (28) (30) (7) (110) (127.7%) (89.5%) (136.7%) (46.7%) (105.5%) Q1 Q2 Q3 Q4 ( Normalized (3) 16.6% 29.5% 22.1% 12.1% 20.4% 18.1% 10.3% 17.8% 19.8% 13.6% 15.8% 15.8% (6.3%) (11.7%) (2.4%) 1.5% (4.6%) (2.4%) ) 15.8% 13.6% 9.5% 7.1% 11.5% (6.9%) 1.7% (5.3%) 5.0% (0.9%) (22.7%) (11.9%) (14.9%) (2.1%) (12.4%) 16.7% 14.2% (4) 14.6% 10.5% (2.1%) (3.7%) 2.6% 1.6% 1.2% (4) (0.1%) (0.9%) (1.3%) 1. 2. 3.
032 +17% +14% 9,542 9,348 : : 8,148 634 545 +8% +110% +8% +104% +24% +21% 1,519 1,482 +17% +12% 1,222 1,205 1,509 1,472 749 674 791 755 780 745 15.0% 15.9% 15.9% 8.3% 8.3% 8.1% 14.8% 15.8% 15.8% 9.2% 8.2% 8.0%
033 3% +9% +6% 25% +22% 30% +16% +26% +17% +23% +11% DMP Solutions +34% +29% B-HEALTH AD VANCE +95% +45% 5,723 6,087 +42% +34% 3,487 3,292 +42% +37% 2,451 603 565 1,676 1,617 1,181
+29.9% +23.7% +24.3% 1,222 1,228 33 19 207 1,595 150 M&A + (76) (44) 0 6 1,519 034
035 +17.3% (14) (9) 0 50 210 (147) (38) 66 +19.0% 674 664 791
036 Issuer 214.7 181.9 CAGR CY1A-17A 3.4% CY 2009 FY 2010/6 147.5 129.6 3.3% 36% 52.3 57.3 58.8 60.7 64.5 67.2 5.1% CY 12 13 14 15 16 17 25.1% CY 2016 FY 2018/6 16.2% 12.4% 10.6% 50% 5.0% 3.6%
037 24% 39.5 39% CAGR CY11A 16A 44.5 2.4% C. 29 % (CY16) 14% 29.2 27.2-1.4% 50% 7% 25% 30% 34% 29% 4% 4% 10.3 11.5 12.1 12.3 14.1 17.4 11.1% CY 2011 2012 2013 2014 2015 2016 Japan US UK Germany France 71% (CY16) MR C. 40 % (CY09)
038 7,551 CAGR CY2016A 2021E 6.8% 40.1% 5,438 3,616 36.4% 0.6% 30.3% 3,517 4Y CAGR 2014/6-2018/6 (2) +88% 1,921 2,323 2,733 3,164 3,573 3,935 15.4% 1.1% 2.6% 4.2% 6.2% 9.4% 2016A 2017E 2018E 2019E 2020E 2021E 0 2014/6 2015/6 2016/6 2017/6 2018/6 2016/6 2017/6 2018/6
039 50 100 140 43 723 10 24 312 51 82 4 226
040
041 DMP Solution AD-VANCE SCOUT H&A CONTEST ACT PACT B-HEALTH Dashboard
042 AD-VANCE
043
044 1 2 3
045 7.0x 6/2018 Q3 189 2,394 34,522 62 37,167 6,449 30,718 6/2018 Q4 9 2,491 34,534 60 37,096 9,124 27,971 (179) (96) 12 (1) (70) 2,674 (2,745) 41,575 8,460 8,757 297 3.6x 3.2x (0.4x) 3.2x 27,971 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2015/6 2016/6 2017/6 2018/6
046 IFRS 2015/6 2016/6 2017/6 2018/6 28,761 32,504 35,514 40,024 (16,372) (17,926) (18,920) (22,372) 12,388 14,578 16,594 17,651 (7,950) (8,956) (10,030) (10,031) 365 272 283 42 (5,399) (168) (31) (57) 9 3 9 2 (586) 5,730 6,825 7,607 53 496 15 528 (3,671) (2,139) (958) (763) (4,204) 4,087 5,882 7,372 215 (848) (1,672) (2,201) (3,988) 3,238 4,210 5,170 (4,320) 2,832 3,706 4,719
047 IFRS IFRS 2015/6/30 2016/6/30 2017/6/30 2018/6/30 2015/6/30 2016/6/30 2017/6/30 2018/6/30 14,247 12,725 15,485 18,409 8,058 8,848 8,952 10,890 7,178 6,124 8,447 9,124 2,978 3,319 2,617 2,500 5,789 6,015 6,388 8,744 2,085 2,492 2,492 3,008 1,279 586 649 540 2,994 3,036 3,842 5,379 56,812 53,839 55,330 56,820 48,683 41,068 39,511 36,871 836 979 1,034 1,152 45,735 38,535 36,880 34,534 53,338 50,788 52,127 53,562 2,947 2,533 2,630 2,335 46,583 45,290 46,067 46,957 56,741 49,916 48,463 47,762 6,755 5,498 6,059 6,605 2,637 2,070 2,169 2,102 14,318 16,647 22,352 27,468 71,060 66,564 70,815 75,230 71,060 66,564 70,815 75,230
IFRS Full Year 048 2015/6 2016/6 2017/6 2018/6 2,298 4,665 5,733 5,610 (4,204) 4,087 5,882 7,372 771 874 871 1,052 4,370 (53) (496) (15) (528) 3,671 2,139 958 763 (60) (338) (131) (2,175) 109 506 (69) 838 4,604 6,772 7,496 7,323 59 33 18 11 (1,355) (1,450) (1,120) (456) (1,009) (690) (660) (1,267) (15,641) 67 (1,348) (2,101) (509) (647) (1,007) (1,026) (16,726) (1,044) 1,594 714 (340) (30) 9,048 (5,602) (2,155) (2,813) 40,088 42,676 237 1,007 (30,030) (48,207) (3,357) (3,636) 1,636-1,149 408 (2,645) (71) (185) (591)
049 IFRS IFRS 2015/6 2016/6 2017/6 2018/6 2015/6 2016/6 2017/6 2018/6 (586) 5,730 6,825 7,607 (4,320) 2,832 3,706 4,719 771 874 871 1,052 909 557 4,370 506 155 4,555 6,604 7,696 8,660 106 120 374 506 155 226 173 481 97 106 120 374 4,370 92 527 527 718 345 312 3 226 173 460 97 1,606 3,494 4,249 4,813 5,921 7,146 8,531 8,757
050 (VA)